Literature DB >> 10950450

Haemoglobin, haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid?

Y O Schumacher1, D Grathwohl, J M Barturen, M Wollenweber, L Heinrich, A Schmid, G Huber, J Keul.   

Abstract

BACKGROUND: In international cycling and cross-country skiing competitions, blood tests are used to unmask the performance enhancing misuse of erythropoietin. Haematocrit (cycling) and haemoglobin (cross-country skiing) limits have been set by international sporting federations (haematocrit 50%, haemoglobin 18.5 g/dl). Athletes tested above these cut-off values are declared unfit for competition. To investigate the validity of these regulations, we studied haemoglobin, haematocrit and red blood cell indices of elite cyclists before erythropoietin became commercially available.
MATERIAL AND METHODS: We investigated 523 blood samples of 92 male elite cyclists (age 16-31 years) from 1978 to 1987. Haematocrit, haemoglobin and red blood cell count were analysed automatically, erythrocyte indices were calculated.
RESULTS: Haemoglobin (-0.3 +/- 1 g/dl), haematocrit (-1.2 +/- 2.8%) and red blood cell count (-0.2 +/- 0.4 x 10(6)/mm3) decreased significantly (p < 0.05) with increasing training workload. The erythrocyte indices showed no significant change. Fifty-four blood samples (10.3%) showed a haematocrit above 50%, one sample presented a haemoglobin mass higher than 18.5 g/dl. During periods of increased workload, less athletes tested above the haematocrit limit.
CONCLUSION: The current haematocrit limit used in blood tests might lead to a high number of false positive tests.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950450     DOI: 10.1055/s-2000-3785

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  9 in total

Review 1.  Haematocrit: within-subject and seasonal variation.

Authors:  Poul Thirup
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Haematological and iron-related parameters in male and female athletes according to different metabolic energy demands.

Authors:  Radoje Milic; Jelena Martinovic; Milivoj Dopsaj; Violeta Dopsaj
Journal:  Eur J Appl Physiol       Date:  2010-09-30       Impact factor: 3.078

Review 3.  Why we should allow performance enhancing drugs in sport.

Authors:  J Savulescu; B Foddy; M Clayton
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

4.  Hemoglobin and hematocrit during an 8 day mountainbike race: a field study.

Authors:  Katharina C Wirnitzer; Martin Faulhaber
Journal:  J Sports Sci Med       Date:  2007-06-01       Impact factor: 2.988

5.  Autologous Blood Doping Induced Changes in Red Blood Cell Rheologic Parameters, RBC Age Distribution, and Performance.

Authors:  Marijke Grau; Emily Zollmann; Janina Bros; Benedikt Seeger; Thomas Dietz; Javier Antonio Noriega Ureña; Andreas Grolle; Jonas Zacher; Hannah L Notbohm; Garnet Suck; Wilhelm Bloch; Moritz Schumann
Journal:  Biology (Basel)       Date:  2022-04-23

Review 6.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

7.  Enhanced Strength and Sprint Levels, and Changes in Blood Parameters during a Complete Athletics Season in 800 m High-Level Athletes.

Authors:  Beatriz Bachero-Mena; Fernando Pareja-Blanco; Juan J González-Badillo
Journal:  Front Physiol       Date:  2017-08-31       Impact factor: 4.566

8.  Association of Hematological Variables with Team-Sport Specific Fitness Performance.

Authors:  Franck Brocherie; Grégoire P Millet; Anna Hauser; Thomas Steiner; Jon P Wehrlin; Julien Rysman; Olivier Girard
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

9.  Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation.

Authors:  Sean Robison; Gauri Rani Karur; Rachel M Wald; Paaladinesh Thavendiranathan; Andrew M Crean; Kate Hanneman
Journal:  J Cardiovasc Magn Reson       Date:  2018-03-15       Impact factor: 5.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.